Grieco, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 8.277
EU - Europa 8.051
AS - Asia 6.397
SA - Sud America 1.491
AF - Africa 159
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 27
Totale 24.436
Nazione #
US - Stati Uniti d'America 8.079
DE - Germania 3.164
SG - Singapore 3.050
CN - Cina 1.790
SE - Svezia 1.379
BR - Brasile 1.253
IT - Italia 778
UA - Ucraina 710
IE - Irlanda 385
FR - Francia 374
GB - Regno Unito 372
VN - Vietnam 296
ID - Indonesia 257
FI - Finlandia 252
IN - India 237
RU - Federazione Russa 212
TR - Turchia 193
PL - Polonia 110
AR - Argentina 102
BD - Bangladesh 96
CA - Canada 91
HK - Hong Kong 87
JP - Giappone 68
IQ - Iraq 64
AT - Austria 51
MX - Messico 51
NL - Olanda 48
BE - Belgio 43
ZA - Sudafrica 43
ES - Italia 37
KR - Corea 34
EC - Ecuador 32
IR - Iran 28
AU - Australia 26
MA - Marocco 24
PK - Pakistan 24
VE - Venezuela 23
EU - Europa 22
SA - Arabia Saudita 22
UZ - Uzbekistan 21
CO - Colombia 20
AE - Emirati Arabi Uniti 19
KE - Kenya 18
RO - Romania 18
JO - Giordania 16
PE - Perù 16
CH - Svizzera 15
EG - Egitto 15
PT - Portogallo 15
CL - Cile 14
CZ - Repubblica Ceca 14
LT - Lituania 13
PA - Panama 13
PY - Paraguay 13
CI - Costa d'Avorio 12
IL - Israele 12
AZ - Azerbaigian 10
TT - Trinidad e Tobago 10
DZ - Algeria 9
TN - Tunisia 9
BO - Bolivia 8
HU - Ungheria 8
JM - Giamaica 8
PH - Filippine 8
AL - Albania 7
MY - Malesia 7
UY - Uruguay 7
DK - Danimarca 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
BZ - Belize 5
CR - Costa Rica 5
GR - Grecia 5
KW - Kuwait 5
LK - Sri Lanka 5
MK - Macedonia 5
NG - Nigeria 5
OM - Oman 5
EE - Estonia 4
ET - Etiopia 4
GE - Georgia 4
KZ - Kazakistan 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IS - Islanda 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
SC - Seychelles 3
BY - Bielorussia 2
CG - Congo 2
GY - Guiana 2
Totale 24.390
Città #
Chandler 1.366
Singapore 1.347
Ashburn 779
Jacksonville 409
Dublin 383
Beijing 347
San Mateo 334
Nanjing 238
Jakarta 237
New York 231
Ann Arbor 223
Frankfurt am Main 207
Wilmington 195
Dallas 193
Los Angeles 192
Boston 189
Nürnberg 180
Hefei 166
Houston 161
Munich 158
Izmir 152
Cattolica 151
Dearborn 139
Milan 127
Princeton 125
Rome 120
Woodbridge 119
Moscow 117
São Paulo 117
Marseille 101
Nanchang 98
Ho Chi Minh City 94
Chicago 85
Hong Kong 81
Seattle 77
Boardman 75
The Dalles 75
Buffalo 73
Helsinki 72
Redwood City 68
Lawrence 66
Hanoi 63
Redmond 63
Fairfield 57
Tianjin 56
Hebei 55
Kraków 55
Santa Clara 48
Tokyo 48
Mountain View 46
Bremen 45
London 45
Shenyang 45
Rio de Janeiro 43
Brussels 42
Kunming 42
Brooklyn 41
University Park 39
Kent 38
Zhengzhou 38
Jiaxing 37
Warsaw 37
Norwalk 36
Changsha 35
Guangzhou 34
San Jose 34
Augusta 32
Hangzhou 32
Seoul 32
Nuremberg 31
Phoenix 31
Turku 31
Belo Horizonte 30
Fremont 28
San Francisco 28
Baghdad 27
Denver 27
Düsseldorf 27
Jinan 27
Washington 27
Dhaka 26
Poplar 25
Toronto 25
Montreal 24
Orem 24
Pune 23
Stockholm 23
Atlanta 22
Bexley 22
Cambridge 22
Vienna 22
Amsterdam 21
Andover 21
Johannesburg 21
Falls Church 20
Simi Valley 20
Brasília 19
Lancaster 19
Tashkent 19
Curitiba 18
Totale 11.635
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 325
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 315
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 251
13C-methionine breath tests for mitochondrial liver function assessment. 245
A phase II study of sunitinib in advanced hepatocellular carcinoma 244
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 229
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 224
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 219
-Hepatic steatosis and vascular disease 214
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 213
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 201
134C-breath tests in the study of mitochondrial liver function 200
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 192
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 190
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 186
Effect of sildenafil on diabetic gastropathy. 178
13C-breath tests in the study of microsomial liver function 178
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 176
13C-methionine breath tests for mitochondrial liver function assessment 172
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 168
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 167
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 164
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 162
Vanishing-recurrent benign liver lesions 159
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 158
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 156
recurrent acute hepatitis associated with use of cetrizine 156
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 154
Cryoglobulinemia: a true internistic disease? 153
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 153
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 153
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 153
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 153
13C-breath tests in the study of mitochondrial liver function 151
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 148
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 148
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 147
Potential use of liver function breath tests in the clinical practice. 147
-Fatty liver and drugs 143
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 142
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 140
Faecal calprotectin concentrations in untreated coeliac patients 140
[The treatment of hepatocellular carcinoma: an update] 140
gastroesophageal reflux disease: facts and uncertaines 139
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 139
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 138
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 137
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 134
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 133
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 133
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 133
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 132
Tromboembolism and breast cancer: the hidden risk for patient and physician 131
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 131
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 131
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 130
Severe giant cell arteritis associated with essential thrombocythaemia. 129
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia 129
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 128
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 125
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 125
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 124
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 124
Advanced colon cancer: staging and prognosis by CEA test 123
Braised liver with herbs: the risks of naturopathic hepatoprotection. 122
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 122
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 120
-Nonalcoholic fatty liver disease: defining a common problem 120
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 120
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 120
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 119
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 118
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 118
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 117
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 117
Alcoholic and nonalcoholic forms of fatty liver disease. 115
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 114
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 114
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 113
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 112
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 111
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 111
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 110
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 110
A giant calcified hepatic mass 110
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 109
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 108
Gender affects 13C-ketoisocaproic acid breath test 108
Is coeliac disease a confounding factor in the diagnosis of NASH? 107
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 107
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 106
Drug-induced hepatitis 105
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 104
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 104
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 103
Acute fatty liver after malaria prophylaxis with mefloquine 103
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 103
Totale 14.729
Categoria #
all - tutte 106.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021830 0 0 0 0 0 63 161 32 194 71 277 32
2021/20221.759 69 162 46 177 124 43 29 288 62 89 320 350
2022/20233.745 493 492 290 543 284 450 163 341 432 51 152 54
2023/20241.879 120 560 77 89 80 272 119 64 23 76 162 237
2024/20253.887 100 108 335 121 305 146 88 213 608 402 776 685
2025/20265.869 1.537 309 673 1.110 1.732 508 0 0 0 0 0 0
Totale 24.668